A Review of Epidemiology and Antifungal Susceptibility of non-Candida albicans species in Iran
Novelty in Biomedicine,
Vol. 13 No. 2 (2025),
19 April 2025
,
Page 126-133
https://doi.org/10.22037/nbm.v13i2.47637
Abstract
Background: Candidiasis is among the most widespread infections caused by fungi species. Although C. albicans still serves as the primary source of this infection, the occurrence and antifungal resistance of non-Candida albicans species seem to be increasing.
Materials and Methods: The data was gathered from multiple sources across Pubmed and Google Scholar using candidiasis, anti-fungal resistance, epidemiology, non-Candida albicans species, and Iran. Different types of articles from 2016 to 2024 regarding candidiasis in various regions of Iran and cases of resistant non-Candida albicans species were included.
Results: In this review article, we analyzed the susceptibility of non-Candida albicans species to multiple anti-fungal agents and observed variable resistance patterns to commonly used agents. However, fluconazole showed resistance more often than other agents, and amphotericin B showed the least amount of resistance overall.
Conclusion: This study aimed to demonstrate the importance of geographical factors and causative species in Iran's resistance pattern and treatment of candidiasis. This can help medical practitioners prescribe the optimum therapeutic agent for candidiasis patients.
- Candidiasis
- Antifungal agents
- Drug resistance
- Epidemiology
- Iran
How to Cite
References
Nouri N, Mohammadi SR, Beardsley J, Aslani P, Ghaffarifar F, Roudbary M, et al. Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units-An In Vitro Study. Metabolites. 2023;13(4).
Badiee P, Boekhout T, Haddadi P, Mohammadi R, Ghadimi-Moghadam A, Soltani J, et al. Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran. Microbiol Spectr. 2022;10(6):e0245322.
Shirazian S, Manifar S, Nodehi RS, Shabani M. Oropharyngeal Candida Colonization in Patients with Acute Myeloid Leukemia. Front Dent. 2020;17(6):1-6.
Arastehfar A, Yazdanpanah S, Bakhtiari M, Fang W, Pan W, Mahmoudi S, et al. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018). Med Mycol. 2021;59(5):422-30.
Arastehfar A, Daneshnia F, Hafez A, Khodavaisy S, Najafzadeh MJ, Charsizadeh A, et al. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Med Mycol. 2020;58(6):766-73.
Charsizadeh A, Mirhendi H, Nikmanesh B, Eshaghi H, Makimura K. Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran. Mycoses. 2018;61(1):22-9.
Badiee P, Badali H, Boekhout T, Diba K, Moghadam AG, Hossaini Nasab A, et al. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC Infect Dis. 2017;17(1):727.
Safari F, Madani M, Kheirollahi M, Mirhendi H. Molecular investigation of the incidence of Candida auris infections at selected hospitals in Iran. Mycoses. 2022;65(12):1137-45.
Kobrazadeh F, Bateni Shalmani A, Mahmoudi S. Candida auris in Iran: A cause for concern? J Infect Public Health. 2024;17(2):370-1.
Ahmadi B, Naeimi B, Ahmadipour MJ, Morovati H, de Groot T, Spruijtenburg B, et al. An autochthonous susceptible Candida auris clade I Otomycosis case in Iran. Journal of Fungi. 2023;9(11):1101.
Armaki MT, Omran SM, Kiakojuri K, Khojasteh S, Jafarzadeh J, Tavakoli M, et al. First fluconazole-resistant Candida auris isolated from fungal otitis in Iran. Current medical mycology. 2021;7(1):51.
Safari F, Madani M, Mirhendi H, Kheirollahi M. Evaluation of Candida auris Colonization using Clinical Skin Swabs: A Single-Center Study in Isfahan, Iran. Journal of Health Reports and Technology. 2022;8(3).
Sharifi M, Badiee P, Abastabar M, Morovati H, Haghani I, Noorbakhsh M, et al. A 3-year study of Candida infections among patients with malignancy: etiologic agents and antifungal susceptibility profile. Frontiers in Cellular and Infection Microbiology. 2023;13:1152552.
Jahanshiri Z, Manifar S, Hatami F. Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC. Iranian Journal of Microbiology. 2023;15(1):163.
Badiee P, Badali H, Boekhout T, Diba K, Moghadam AG, Hossaini Nasab A, et al. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC infectious diseases. 2017;17:1-8.
Sharifzadeh A, Shokri H. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares. Equine veterinary journal. 2021;53(1):94-101.
Golestannejad Z, Khozeimeh F, Dehghan P, Najafizade N, Faghihian E, Kheirkhah M, et al. Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy. Dental Research Journal. 2022;19(1):99.
Arastehfar A, Daneshnia F, Hafez A, Khodavaisy S, Najafzadeh M-J, Charsizadeh A, et al. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Medical Mycology. 2020;58(6):766-73.
Zarrinfar H, Kord Z, Fata A. High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran. Current medical mycology. 2021;7(3):18.
Amanloo S, Shams-Ghahfarokhi M, Ghahri M, Razzaghi-Abyaneh M. Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile. Medical Mycology. 2018;56(2):207-15.
Arastehfar A, Daneshnia F, Zomorodian K, Najafzadeh MJ, Khodavaisy S, Zarrinfar H, et al. Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1. Antimicrobial agents and chemotherapy. 2019;63(7):10.1128/aac. 02503-18.
Badiee P, Boekhout T, Haddadi P, Mohammadi R, Ghadimi-Moghadam A, Soltani J, et al. Epidemiology and antifungal susceptibility of Candida species isolated from 10 tertiary care hospitals in Iran. Microbiology spectrum. 2022;10(6):e02453-22.
Nouri N, Mohammadi SR, Beardsley J, Aslani P, Ghaffarifar F, Roudbary M, et al. Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units—An In Vitro Study. Metabolites. 2023;13(4):580.
Shirazian S, Manifar S, Nodehi RS, Shabani M. Oropharyngeal candida colonization in patients with acute myeloid Leukemia. Frontiers in dentistry. 2020;17.
Lotfali E, Kordbacheh P, Mirhendi H, Zaini F, Ghajari A, Mohammadi R, et al. Antifungal susceptibility analysis of clinical isolates of Candida parapsilosis in Iran. Iranian journal of public health. 2016;45(3):322.
Arastehfar A, Yazdanpanah S, Bakhtiari M, Fang W, Pan W, Mahmoudi S, et al. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018). Medical mycology. 2021;59(5):422-30.
Arastehfar A, Khodavaisy S, Daneshnia F, Najafzadeh MJ, Mahmoudi S, Charsizadeh A, et al. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014-2019). Front Cell Infect Microbiol. 2019;9:264.
Davari A, Haghani I, Hassanmoghadam F, Nabili M, Shokohi T, Hedayati MT, et al. Echinocandin resistance in Candida parapsilosis sensu stricto: Role of alterations in CHS3, FKS1 and Rho gene expression. Journal of Global Antimicrobial Resistance. 2020;22:685-8.
Sadrossadati SZ, Ghahri M, Fooladi AAI, Sayyahfar S, Beyraghi S, Baseri Z. Phenotypic and genotypic characterization of Candida species isolated from candideamia in Iran. Current medical mycology. 2018;4(2):14.
- Abstract Viewed: 44 times
- pdf Downloaded: 14 times